---
title: 'Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic
  fatigue syndrome - State of the art: Report of the 2nd international meeting at
  the Charité fatigue center'
date: '2023-09-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37742748/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230925181020&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a devastating
  disease affecting millions of people worldwide. Due to the 2019 pandemic of coronavirus
  disease (COVID-19), we are facing a significant increase of ME/CFS prevalence. On
  May 11th to 12th, 2023, the second international ME/CFS conference of the Charité
  Fatigue Center was held in Berlin, Germany, focusing on pathomechanisms, diagnosis,
  and treatment. During the two-day conference, more than 100 researchers from ...
disable_comments: true
---
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a devastating disease affecting millions of people worldwide. Due to the 2019 pandemic of coronavirus disease (COVID-19), we are facing a significant increase of ME/CFS prevalence. On May 11th to 12th, 2023, the second international ME/CFS conference of the Charité Fatigue Center was held in Berlin, Germany, focusing on pathomechanisms, diagnosis, and treatment. During the two-day conference, more than 100 researchers from ...